---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275914162.md"
description: "Moolec Science shares are trading higher after the company announced results from the crushing process of its U.S. GLASO1 safflower platform."
datetime: "2026-02-13T14:14:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275914162.md)
  - [en](https://longbridge.com/en/news/275914162.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275914162.md)
---

# 

Moolec Science shares are trading higher after the company announced results from the crushing process of its U.S. GLASO1 safflower platform.

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [MLECW.US](https://longbridge.com/en/quote/MLECW.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [MLEC.US](https://longbridge.com/en/quote/MLEC.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [09:13 ETTranspire Bio's ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA](https://longbridge.com/en/news/285949973.md)
- [Ernexa Therapeutics Stock Climbs On Breakthrough Preclinical Data](https://longbridge.com/en/news/285400985.md)
- [Canada's Knight Therapeutics Q1 revenue jumps 69%, beats estimates](https://longbridge.com/en/news/285531982.md)
- [bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026 | BIAF Stock News](https://longbridge.com/en/news/286107351.md)
- [Pliant Therapeutics Q1 net loss narrows on lower expenses](https://longbridge.com/en/news/285998196.md)